Skip to main content
Premium Trial:

Request an Annual Quote

Telesis Bio: William Kullback

Synthetic biology company Telesis Bio has appointed William Kullback as CFO. Kullback previously was CFO of BioLegend where he helped lead that company's $5.25 billion September 2021 sale to Revvity (PerkinElmer at the time). Before BioLegend, Kullback was CFO of Lombard Medical from 2014 to 2017, prior to its acquisition by MicroPort Scientific. He holds an MBA and bachelor's degree from the State University of New York at Buffalo.